Elevations in the levels of inflammatory cytokines as seen in COVID-19 further worsen insulin resistance [19], and levels of inflammatory markers and markers of COVID-19 severity, including C-reactive protein, have been found to be higher in patients with newly diagnosed diabetes, compared to those with pre-existing DM [20]. Here, CRP is linked to COVID-19.